testosterone propionate has been researched along with Prostatic Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Clement, OO; Freeman, CM; Handratta, VD; Hartmann, RW; Njar, VC; Vasaitis, TS | 1 |
| Lind, J; Sinha, AA; Wilson, MJ | 1 |
| Badalassi, F; Bertozzi, F; Bradley, SR; Fejzic, A; Gardell, LR; Lewinsky, R; Lund, BW; Olsson, R; Pawlas, J; Piu, F; Schlienger, N; Tabatabaei, A; Thygesen, MB | 1 |
| Cheng, Q; Huang, M; Kochhar, U; Lee, JH; Ou, Z; Pflug, BR; Ren, S; Xie, W; Xu, M; Zhang, B | 1 |
| Chaĭkovs'ka, LV; Poliakova, LI; Reznikov, OH; Sachyns'ka, OV | 1 |
| CATTANI, L; DEMETZ, A; TOFFOL, A | 1 |
| Chen, RY; Chuu, CP; Fukuchi, J; Hiipakka, RA; Kokontis, JM; Liao, S | 1 |
| Bosland, MC; Johnson, WD; Lubet, RA; McCormick, DL; Steele, VE | 1 |
| Bosland, MC; Haryu, TM; Johnson, WD; Lubet, RA; McCormick, DL; Steele, VE | 1 |
| Abate-Shen, C; Aronow, BJ; Banach-Petrosky, W; Gao, H; Jessen, WJ; Ouyang, X; Quinn, J; Rao, J | 1 |
| Bisson, JF; Guardia-Llorens, MA; Hidalgo, S; Messaoudi, M; Rozan, P | 1 |
11 other study(ies) available for testosterone propionate and Prostatic Neoplasms
| Article | Year |
|---|---|
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
Topics: Algorithms; Antineoplastic Agents; Azoles; Binding Sites; Enzyme Inhibitors; Humans; Hydrogen Bonding; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding; Quantitative Structure-Activity Relationship; Steroid 17-alpha-Hydroxylase; Steroids | 2003 |
Induction of a heparin-stimulated serine proteinase in sex accessory gland tumors of the Lobund-Wistar rat.
Topics: Animals; Heparin; Male; Methylnitrosourea; Prostate; Prostatic Neoplasms; Rats; Rats, Wistar; Seminal Vesicles; Serine Proteases; Sulfones; Testosterone Propionate | 2015 |
Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
Topics: Administration, Oral; Androgen Receptor Antagonists; Androgens; Animals; Azabicyclo Compounds; Dogs; Drug Design; Humans; Ligands; Male; Mice; Microsomes, Liver; Mutation; NIH 3T3 Cells; Orchiectomy; Prostatic Neoplasms; Rats; Receptors, Androgen; Structure-Activity Relationship; Substrate Specificity; Testosterone Propionate | 2009 |
Pregnane X receptor as a therapeutic target to inhibit androgen activity.
Topics: Animals; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Gene Expression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Orchiectomy; Pregnane X Receptor; Pregnenolone Carbonitrile; Prostate; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Regeneration; Sulfotransferases; Testosterone; Testosterone Propionate | 2010 |
[Effects of cytokine-like polypeptide EMAP II and flutamide on the testosterone-stimulated prostate of castrated rats].
Topics: Androgen Antagonists; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Proliferation; Cytokines; Drug Synergism; Flutamide; Male; Neoplasm Proteins; Orchiectomy; Prostate; Prostatic Neoplasms; Rats; Rats, Wistar; RNA-Binding Proteins; Testosterone Propionate | 2011 |
[Changes in blood and urinary calcium values induced by testosterone propionate in patients with prostatic cancer].
Topics: Calcium Metabolism Disorders; Calcium, Dietary; Humans; Male; Prostatic Neoplasms; Testosterone; Testosterone Propionate; Urinary Tract | 1963 |
Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
Topics: Androgens; Animals; Cell Growth Processes; Cholesterol; Disease Progression; DNA-Binding Proteins; Humans; Hydrocarbons, Fluorinated; Liver X Receptors; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Orchiectomy; Orphan Nuclear Receptors; Prostatic Neoplasms; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Testosterone; Testosterone Propionate; Xenograft Model Antitumor Assays | 2006 |
Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Synergism; Humans; Isoflavones; Male; Methylnitrosourea; Prostatic Neoplasms; Random Allocation; Rats; Rats, Wistar; Testosterone Propionate; Time Factors; Trypsin Inhibitor, Bowman-Birk Soybean | 2007 |
Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat.
Topics: Animals; Carcinogens; Cyproterone Acetate; Diet, Reducing; Dose-Response Relationship, Drug; Humans; Male; Methylnitrosourea; Prevalence; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Testosterone Propionate; Treatment Outcome; Weight Gain | 2007 |
Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.
Topics: Androgens; Animals; Disease Progression; Homeodomain Proteins; Male; Mice; Mice, Inbred C57BL; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; PTEN Phosphohydrolase; Testosterone Propionate; Transcription Factors | 2007 |
Protective effect of Acticoa powder, a cocoa polyphenolic extract, on prostate carcinogenesis in Wistar-Unilever rats.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Body Weight; Cacao; Carcinogens; Cell Transformation, Neoplastic; Cocarcinogenesis; Disease Models, Animal; Flavonoids; Male; Methylnitrosourea; Phenols; Plant Extracts; Polyphenols; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone Propionate | 2008 |